GB0309509D0 - Pharmaceutical compositions and their uses - Google Patents

Pharmaceutical compositions and their uses

Info

Publication number
GB0309509D0
GB0309509D0 GBGB0309509.8A GB0309509A GB0309509D0 GB 0309509 D0 GB0309509 D0 GB 0309509D0 GB 0309509 A GB0309509 A GB 0309509A GB 0309509 D0 GB0309509 D0 GB 0309509D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0309509.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai London Research Laboratories Ltd
Original Assignee
Eisai London Research Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai London Research Laboratories Ltd filed Critical Eisai London Research Laboratories Ltd
Priority to GBGB0309509.8A priority Critical patent/GB0309509D0/en
Publication of GB0309509D0 publication Critical patent/GB0309509D0/en
Priority to PCT/GB2004/001691 priority patent/WO2004096217A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
GBGB0309509.8A 2003-04-25 2003-04-25 Pharmaceutical compositions and their uses Ceased GB0309509D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0309509.8A GB0309509D0 (en) 2003-04-25 2003-04-25 Pharmaceutical compositions and their uses
PCT/GB2004/001691 WO2004096217A1 (en) 2003-04-25 2004-04-21 Use of n-type calcium channel inhibitors in treating demyelinating diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0309509.8A GB0309509D0 (en) 2003-04-25 2003-04-25 Pharmaceutical compositions and their uses

Publications (1)

Publication Number Publication Date
GB0309509D0 true GB0309509D0 (en) 2003-06-04

Family

ID=9957238

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0309509.8A Ceased GB0309509D0 (en) 2003-04-25 2003-04-25 Pharmaceutical compositions and their uses

Country Status (2)

Country Link
GB (1) GB0309509D0 (en)
WO (1) WO2004096217A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008534630A (en) * 2005-04-08 2008-08-28 ニューロメッド ファーマシューティカルズ リミテッド Method of combination therapy including N-type calcium channel blockers for pain relief
US8304434B2 (en) 2007-10-04 2012-11-06 Merck Sharp & Dohme Corp. Substituted aryl sulfone derivatives as calcium channel blockers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992007564A2 (en) * 1990-10-30 1992-05-14 The Wellcome Foundation Limited Method of treating demyelinating disease
DE4223163A1 (en) * 1992-07-10 1994-01-13 Karl Und Veronica Carstens Sti Treatment of demyelination disorders, esp. multiple sclerosis - comprises admin. of benzofuran, psoralen or furochromone calcium channel blocker
EP1246635A4 (en) * 1999-12-30 2004-09-01 Univ Utah Res Found O-superfamily conotoxin peptides
AU2001262252A1 (en) * 2000-05-15 2001-11-26 Bayer Aktiengesellschaft Means for treating attacks of auto-immune diseases
US7470718B2 (en) * 2000-10-03 2008-12-30 Albert Einstein College Of Medicine Of Yeshiva University Method for treating a demyelinating condition
US6455553B1 (en) * 2000-10-03 2002-09-24 Albert Einstein College Of Medicine Of Yeshiva University Method for treating a demyelinating condition
AU2002248553A1 (en) * 2001-03-07 2002-09-24 Cognetix, Inc Linear y-carboxyglutamate rich conotoxins

Also Published As

Publication number Publication date
WO2004096217A1 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
IL170758A0 (en) 7-amino-isoindolyl compounds and their pharmaceutical uses
HK1084883A1 (en) 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof
GB0320382D0 (en) Pharmaceutical compositions
GB0327723D0 (en) Pharmaceutical compositions
IL173726A (en) Pharmaceutical compositions comprising n-n-dihaloamino acid and uses thereof
IL173602A0 (en) Heteroarylaminosulfonylphenyl derivatives and pharmaceutical compositions containing the same
IL173627A0 (en) 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives and pharmaceutical compositions containing the same
IL173051A0 (en) N-glucoside derivatives and pharmaceutical compositions containing the same
IL171997A0 (en) Pyrrolodihydroisoquinoline derivatives and pharmaceutical compositions containing the same
IL175214A0 (en) 2-cyanopyrrolidinecarboxamide derivatives and pharmaceutical compositions containing the same
PL2218342T3 (en) Novel nutraceutical compositions and use thereof
IL170313A (en) Diarylcycloalkyl derivatives and pharmaceutical compositions comprising them
IL172159A0 (en) 2-oxo-pyridine derivatives and pharmaceutical compositions containing the same
IL197889A (en) Pyridylvinylazacyclopentane compound and pharmaceutical compositions comprising same
ZA200605080B (en) Pharmaceutical compositions
HU0301154D0 (en) Pharmaceutical composition
GB0300427D0 (en) Pharmaceutical composition
GB0300531D0 (en) Pharmaceutical compositions
EP1648411A4 (en) Pharmaceutical compositions
GB0307866D0 (en) Pharmaceutical composition
IL176077A0 (en) 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them
EP1699458A4 (en) Pharmaceutical composition
GB0329232D0 (en) Pharmaceutical composition
GB0317663D0 (en) Pharmaceutical composition
GB0300885D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)